New procedure offers hope to patients at high risk for recurrent stroke

Surgeons at NewYork-Presbyterian Hospital/Weill Cornell Medical Center are the first in the New York City metropolitan area to successfully implant into the brain arteries a new stent specifically designed to treat high-risk stroke patients.

Electrocardiogram helps predict risk for congestive heart failure in hypertensive patients

An electrocardiogram is an effective tool for detecting risk of congestive heart failure (CHF) in patients with hypertension, according to a new study by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

Survival triples for 1,000 AIDS patients receiving antiretroviral therapy in Haiti

Many patients with AIDS in Haiti who received antiretroviral therapy had a one-year survival of 87 percent for adults and 98 percent for children, triple the 30 percent one-year survival of Haitian patients without the therapy, according to a study.

Katie Couric salutes 'heroes' who treat cancer at Jay Monahan Center

'You are the unsung heroes and heroines of our society,' media star Katie Couric, co-anchor of NBC's 'Today' show, said in a moving speech to doctors and other health-care professionals gathered to discuss crucial updates and issues in gastrointestinal cancers.

Hypnotic suggestion can reduce conflict in human brain

A new study using an old, misunderstood technique -- hypnotic suggestion -- finds the brain can override responses experts have long assumed to be ingrained and automatic, such as reading. (Aug. 1, 2005)

Revised Hippocratic Oath resonates with graduates

Revisiting a hallowed ritual for doctors, a committee within the Weill Cornell Medical College convened this spring to craft an updated Hippocratic Oath, one that responds to the state of modern medicine. Written in ancient Greece, the oath expresses principles still fundamental to the practice of medicine today. (June 22, 2005)

Weill Cornell/ludwig institute for cancer research collaboration identifies two antigens as targets for multiple myeloma vaccine

Vaccines that train the immune system to seek out and destroy malignant cells are at the cutting edge of cancer treatment. Now, joint research – conducted by researchers at Weill Medical Cornell and at the Ludwig Institute for Cancer Research Memorial Sloan-Kettering Cancer Center Branch in New York – has pinpointed two proteins that seem ideal targets for a vaccine against multiple myeloma.

Extensive brain activity while listening to speech suggests awareness in minimally conscious patients

For the first time, advanced neurological imaging suggests the brains of minimally conscious patients recognize and respond to speech in ways similar to healthy individuals, according to a team of researchers. (Feb. 7, 2005)

Silencing human gene through new science of epigenetics

For the first time, scientists have shown how the activity of a gene associated with normal human development, as well as the occurrence of cancer and several other diseases, is repressed epigenetically – by modifying not the DNA code of a gene, but instead the spool-like histone proteins around which DNA tightly wraps itself in the nucleus of cells in the body.